Pemetrexed News and Research

RSS
Promising results from combination therapy of pemetrexed concurrent with radiation in lung cancer

Promising results from combination therapy of pemetrexed concurrent with radiation in lung cancer

Results from VeriStrat biomarker analysis of Phase III trial presented at European Lung Cancer Conference

Results from VeriStrat biomarker analysis of Phase III trial presented at European Lung Cancer Conference

PCFT helps in effectively targeting cytotoxic antifolates to tumors: Study

PCFT helps in effectively targeting cytotoxic antifolates to tumors: Study

Rosetta Genomics' Philadelphia lab commences FNA cell block sample analysis with miRview squamous test

Rosetta Genomics' Philadelphia lab commences FNA cell block sample analysis with miRview squamous test

UK NICE recommends Eli Lilly's ALIMTA as maintenance therapy for nonsquamous NSCLC

UK NICE recommends Eli Lilly's ALIMTA as maintenance therapy for nonsquamous NSCLC

BioNumerik Pharmaceuticals commences patient treatment in Tavocept Phase III trial

BioNumerik Pharmaceuticals commences patient treatment in Tavocept Phase III trial

Novelos Therapeutics to conclude pivotal Phase 3 trial in advanced non-small cell lung cancer

Novelos Therapeutics to conclude pivotal Phase 3 trial in advanced non-small cell lung cancer

Eli Lilly provides financial guidance for 2010

Eli Lilly provides financial guidance for 2010

Updated NCCN Guidelines include maintenance therapy for patients with metastatic disease

Updated NCCN Guidelines include maintenance therapy for patients with metastatic disease

Pfizer to commence Phase 3 trial of oral c-Met and ALK inhibitor

Pfizer to commence Phase 3 trial of oral c-Met and ALK inhibitor

Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit

Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit

FDA approves Alimta (pemetrexed) for advanced lung cancer

FDA approves Alimta (pemetrexed) for advanced lung cancer

Updated guidelines for ovarian cancer

Updated guidelines for ovarian cancer

Tissue analyses indicate survival benefits for some lung cancer patients

Tissue analyses indicate survival benefits for some lung cancer patients

New clinical trial for patients with asbestos-associated lung cancer

New clinical trial for patients with asbestos-associated lung cancer

AstraZeneca completes enrollment in phase III studies of cancer drug vandetanib

AstraZeneca completes enrollment in phase III studies of cancer drug vandetanib

Genomic profiling of lung tumors helps doctors choose most effective treatment

Genomic profiling of lung tumors helps doctors choose most effective treatment

Studies try to shed light on impact of race

Studies try to shed light on impact of race

Patients around the world face stark inequalities in access to cancer treatment

Patients around the world face stark inequalities in access to cancer treatment

ESMO explores collaboration to fight cancer on all fronts

ESMO explores collaboration to fight cancer on all fronts